Skip to main content
Latest news
Browse specialties
Breast cancer Genitourinary cancers Lung & thoracic cancers
In focus
Next-generation sequencing: Emerging biomarkers in thyroid and NSCLCs ctDNA and bladder cancer: Current understanding and beyond ROS1 fusion-positive NSCLC NSCLC driver mutations: Discussing the importance of RET, ALK and ROS1 alterations in NSCLC Early-stage NSCLC management: Surgery, targeted treatment and immunotherapy ALK fusion-positive NSCLC: International approaches to management RET fusion-positive NSCLC: Informing on the use of pralsetinib for patients with RET fusion-positive, advanced NSCLC COVID-19 & cancer
Conferences
SABCS 2022 ESMO 2022 2022 ASCO Annual Meeting
About us
Medicine Matters Oncology
EXTENDED SEARCH

01-02-2017 | Image

Figure 1: Translocations involved in multiple myeloma.

In this Circos plot, line thickness correlates with the frequency of the translocations. The plot is based on data from whole-exome sequencing — with baits on MYC, IGH, IGL and IGK loci — of tumour samples from 463 patients with newly diagnosed multiple myeloma8. The co-occurrence of partner gene mutations is indicated in orange.

print
PRINT
Image Credits